Given that IL-8 is a pro-inflammatory chemokine that is implicated in tumor progression, angiogenesis, and the formation of a protumorigenic microenvironment in CRC, the suppressive effect of ECH147 on IL-8 expression suggests promising therapeutic potential for modulating the tumor-associated inflammatory response [11]. The gene discussed is CXCL8; the disease is colorectal carcinoma.